Elpen Pharmaceutical is a company specializing in the development, production, and marketing of generic products for CNS, respiratory, oncology diseases, and bacterial infections. It produces drugs in various pharmaceutical forms, including solid and liquid oral dosage forms, inhalers, lyophilized forms, and liquids for injection. Additionally, the company offers a breath activated dry powder inhaler, named Elpenhaler, for the administration of multiple single doses of medicine to treat patients suffering from asthma or COPD (Lung Obstructive diseases).